research alliance
MultiOmic Health, Mesh Bio Partner to Study Chronic Metabolic Disease for Drug, Dx Development
The companies will build a diverse research cohort with multiomics data and apply AI as they seek to improve diagnostics and advance drug discovery.
NHS, Genomics PLC to Integrate Polygenic Risk Scores With Traditional Cardiovascular Risk Factors
A newly launched pilot study aims to demonstrate the effectiveness of genetic risk assessment in preventing cardiovascular disease in England.
Exact Sciences, Jefferson Health to Study Blood-Based Multicancer Early Detection Test
The partners will survey doctors, care coordinators, and patients on metrics like test safety and efficacy, and how to best implement multicancer testing.
KDx Diagnostics to Launch Clinical Study of Bladder Cancer Test in Hematuria Patients
The urine-based test, which uses a novel cancer biomarker to detect new and recurrent bladder cancer, has both the CE mark and FDA breakthrough device designation.
The project, being coordinated by UCSF and the University of Heidelberg, has a total budget of $20 million and is expected to run through 2025.